Month: June 2023

ARCHBOLD, Ohio, June 14, 2023 (GLOBE NEWSWIRE) — F&M Bank (“F&M), an Archbold, Ohio based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today announced its newest full-service office is now open. The new office is located at 335 South College Ave., Oxford, OH 45056. Phil Lucas, Regional President, stated: “We are excited to expand our presence in Oxford and surrounding areas. For the past three years, we have served the Oxford market through a highly productive Loan Production Office. As a community-focused financial institution, we believe our core values and relationship-based banking model meet the personal and business banking needs of Oxford. We look forward to supporting families and businesses in the greater Oxford area.” As a full-service office, F&M Bank will offer the Oxford community...

To Nasdaq Copenhagen A/S                        14th June 2023                                        Announcement no. 57/2023 CORRECTION: The following ISIN are erroneously attached to this notice: DK0009413445, DK0009413528 og DK0009413601 Final terms for bonds to be listed 20thJune 2023 On 20th June 2023, Jyske Realkredit A/S will be listing new Covered Bonds (SDO). Final terms for the bonds are attached to this announcement. The full prospectus for the Bond consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated February 21st, 2023. Jyske Realkredit’s base prospectus is available on Jyske...

Use of HemeScreen® technology enables diagnosis without the need for painful, invasive sampling NEW HAVEN, Conn., June 14, 2023 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen Cytopenia panel as part of the diagnostic process for molecular identification of driver mutations in a patient with a history of transfusion-dependent anemia and experiencing progressive weakness and neurological symptoms. The findings point to an underlying myeloid stem cell disorder, including a myelodysplastic syndrome and possibly a higher-grade myeloid neoplasm. A major advantage in the case work-up using the Omnia methodology was the ability to detect these driver mutations using only a peripheral blood sample and not requiring a further bone marrow biopsy to confirm pathology suspicions....

Northrop Grumman Enhances G/ATOR with New Performance Capabilities Northrop Grumman successfully completed Full-Rate Production Lot One of G/ATOR and will deliver 46 awarded systems to the Marine Corps. (Photo Credit: Northrop Grumman)BALTIMORE, June 14, 2023 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) continues to enhance the functionality of AN/TPS-80 Ground/Air Task-Oriented Radar (G/ATOR) with new performance upgrades that will extend the range and add advanced capabilities following the completion of Full Rate Production lot one to the U.S. Marine Corps. While in production, G/ATOR has proven to be an agile expeditionary air defense capability suitable for air base defense. Based on the success of the fielded systems, new performance upgrades that will extend the range and capability are planned for next...

SAN CLEMENTE, Calif., June 14, 2023 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced participation in the following investor and industry conferences in June:June 20-21: Maxim Virtual Healthcare Conference. Paul F. Hickey, President and Chief Executive Officer, and Tom Stankovich, Chief Financial Officer, will present a company overview at this virtual conference on Tuesday, June 20, 2023, at 2:00 pm ET. A live webcast of the presentation will be available on the “Events and Presentations” section of ReShape’s website at: https://ir.reshapelifesciences.com/events-and-presentations. An archived replay will be available on the company’s website for a period of 90 days after the conference.June 22: Life Sciences Investor Forum....